Impossible to say....
Right now the technical chart looks very powerful, with all these new highs on strong trading volume. If buying strength continues on good vol., we'll see a lot more new highs, obviously not every day.... The stock, as is usually the case with other runners, will have to stop here and there to "breathe," i.e., consolidate, and allow new waves of buying to enter.
There's the likelihood of more sell-side analysts coming on board initiating coverage with outsized PTs.
Even more impactful on cont'd share-price upward movement would be other big biotech investors announcing they've taken positions of 5% or greater, like Acuista last Friday.
Obviously if the stockmarket were to plunge, ACST shareprice could be effected, but then again it may not be effected.
Also lurking for good or ill is different kind of news for AMRN and their Vascepa drug. Some kind of news may rightly or wrongly be interpreted by the mkt as good or bad for ACST. We've seen that happen before.
So there are lots of variables.
News 
Market Data 
Discover 
